Applied BioCode (Taiwan) Today
Applied BioCode is selling for under 24.35 as of the 25th of February 2026; that is 0.61 percent decrease since the beginning of the trading day. The stock's lowest day price was 24.2. The performance scores are derived for the period starting the 27th of November 2025 and ending today, the 25th of February 2026. Click here to learn more.
Valuation
Check how we calculate scores
Applied Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Applied BioCode's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Applied BioCode or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Applied BioCode (6598) is traded on Taiwan Stock Exchange in Taiwan and employs 11 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.31 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Applied BioCode's market, we take the total number of its shares issued and multiply it by Applied BioCode's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Applied BioCode operates under Healthcare sector and is part of Medical Devices industry. The entity has 81.76 M outstanding shares.
Applied BioCode has accumulated about 819.75 M in cash with (151.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.03.
Check Applied BioCode Probability Of Bankruptcy
Applied BioCode Risk Profiles
Although Applied BioCode's alpha and beta are two of the key measurements used to evaluate Applied BioCode's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.48 | |||
| Semi Deviation | 1.67 | |||
| Standard Deviation | 2.19 | |||
| Variance | 4.78 |
Applied Stock Against Markets
Applied Stock Analysis Notes
About 43.0% of the company shares are owned by insiders or employees . The book value of Applied BioCode was presently reported as 10.71. The company recorded a loss per share of 2.63. Applied BioCode had not issued any dividends in recent years. Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex testing products for the In-Vitro diagnostics market. The company was founded in 2016 and is based in Santa Fe Springs, California. APPLIED BIOCODE operates under Medical Devices classification in Taiwan and is traded on Taiwan Stock Exchange. For more info on Applied BioCode please contact the company at 833 246 2633 or go to https://www.apbiocode.com.Applied BioCode Investment Alerts
| Applied BioCode is not yet fully synchronised with the market data | |
| The company reported the revenue of 319.96 M. Net Loss for the year was (165.2 M) with profit before overhead, payroll, taxes, and interest of 189.37 M. | |
| Applied BioCode has accumulated about 819.75 M in cash with (151.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.03. | |
| Roughly 43.0% of the company shares are owned by insiders or employees |
Applied Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.31 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Applied BioCode's market, we take the total number of its shares issued and multiply it by Applied BioCode's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Applied Profitablity
Applied BioCode's profitability indicators refer to fundamental financial ratios that showcase Applied BioCode's ability to generate income relative to its revenue or operating costs. If, let's say, Applied BioCode is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Applied BioCode's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Applied BioCode's profitability requires more research than a typical breakdown of Applied BioCode's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.47) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.47. Applied BioCode Outstanding Bonds
Applied BioCode issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Applied BioCode uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Applied bonds can be classified according to their maturity, which is the date when Applied BioCode has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Applied BioCode Predictive Daily Indicators
Applied BioCode intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Applied BioCode stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 5194.02 | |||
| Daily Balance Of Power | (0.25) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 24.5 | |||
| Day Typical Price | 24.45 | |||
| Price Action Indicator | (0.22) | |||
| Period Momentum Indicator | (0.15) | |||
| Relative Strength Index | 57.69 |
Applied BioCode Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Applied BioCode stock to make a market-neutral strategy. Peer analysis of Applied BioCode could also be used in its relative valuation, which is a method of valuing Applied BioCode by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Applied BioCode Corporate Management
Elected by the shareholders, the Applied BioCode's board of directors comprises two types of representatives: Applied BioCode inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Applied. The board's role is to monitor Applied BioCode's management team and ensure that shareholders' interests are well served. Applied BioCode's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Applied BioCode's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jaca Huang | Chief Officer | Profile | |
| YuTsung Chou | Chief Officer | Profile | |
| Michael Aye | Chief Officer | Profile | |
| Christopher Bernard | Chief Officer | Profile | |
| JauTung Pan | Accounting Supervisor | Profile | |
| Frank Mitchell | HR Director | Profile | |
| Julian Sanchez | Director HR | Profile |
Additional Tools for Applied Stock Analysis
When running Applied BioCode's price analysis, check to measure Applied BioCode's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied BioCode is operating at the current time. Most of Applied BioCode's value examination focuses on studying past and present price action to predict the probability of Applied BioCode's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied BioCode's price. Additionally, you may evaluate how the addition of Applied BioCode to your portfolios can decrease your overall portfolio volatility.